SC 13G/A

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

Transgenomic, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

89365K206

(CUSIP Number of Class of Securities)

Ryan J. York

Davis Wright Tremaine

1201 Third Avenue, Suite 2200

Seattle, Washingtion 98101

(206) 622-3150

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 31, 2012

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

(Continued on following pages)

Page 1 of 10


SCHEDULE 13G

 

CUSIP No. 89365K206      

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

Kevin Douglas

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

Sole Voting Power

 

-0-

   6   

Shared Voting Power

 

6,369,813 (1)

   7   

Sole Dispositive Power

 

-0-

   8   

Shared Dispositive Power

 

8,514,812 (1)(2)

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

8,514,812 (1)(2)

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ¨

 

11  

Percent of Class Represented by Amount in Row (9)

 

9.7% (3)

12  

Type of Reporting Person

 

IN

 

(1) Kevin Douglas and his wife, Michelle Douglas, jointly as the beneficiaries and co-trustees of the K&M Douglas Trust, hold 2,260,000 shares and a currently exercisable warrant to purchase 925,925 shares at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares. In addition, Kevin Douglas and Michelle Douglas are co-trustees of the James Douglas and Jean Douglas Irrevocable Descendants’ Trust, which holds 2,420,000 shares and a currently exercisable warrant to purchase 763,888 shares at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(2) Kevin Douglas has dispositive power with respect to 1,120,000 shares held by the Douglas Family Trust and 400,000 shares held by James E. Douglas III. Kevin Douglas also has dispositive power with respect to currently exercisable warrants to purchase 393,518 and 231,481 shares of common stock held by the Douglas Family Trust and James E. Douglas III, respectively, at a price of $1.08 per share; however, these warrants are exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(3) Based on 88,245,725 shares of common stock outstanding, calculated as follows (a) 71,645,725 shares of the Issuer’s common stock outstanding as of November 7, 2012 as reported on its Form 10-Q for the quarter ended September 30, 2012 filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2012, and (b) an additional 16,600,000 shares issued in a private placement, as disclosed by the Issuer in a current report on Form 8-K/A filed with the SEC on January 31, 2013.

 

Page 2 of 10


SCHEDULE 13G

 

CUSIP No. 89365K206      

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

Michelle Douglas

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

Sole Voting Power

 

-0-

   6   

Shared Voting Power

 

6,369,813 (1)

   7   

Sole Dispositive Power

 

-0-

   8   

Shared Dispositive Power

 

6,369,813 (1)

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

6,369,813 (1)

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ¨

 

11  

Percent of Class Represented by Amount in Row (9)

 

7.2% (2)

12  

Type of Reporting Person

 

IN

 

(1) Kevin Douglas and his wife, Michelle Douglas, jointly as the beneficiaries and co-trustees of the K&M Douglas Trust, hold 2,260,000 shares and a currently exercisable warrant to purchase 925,925 shares at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares. In addition, Kevin Douglas and Michelle Douglas are co-trustees of the James Douglas and Jean Douglas Irrevocable Descendants’ Trust, which holds 2,420,000 shares and a currently exercisable warrant to purchase 763,888 shares at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(2) Based on 88,245,725 shares of common stock outstanding, calculated as follows (a) 71,645,725 shares of the Issuer’s common stock outstanding as of November 7, 2012 as reported on its Form 10-Q for the quarter ended September 30, 2012 filed with the SEC on November 8, 2012, and (b) an additional 16,600,000 shares issued in a private placement, as disclosed by the Issuer in a current report on Form 8-K/A filed with the SEC on January 31, 2013.

 

Page 3 of 10


SCHEDULE 13G

 

CUSIP No. 89365K206      

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

James E. Douglas III

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

California

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

Sole Voting Power

 

631,481 (1)

   6   

Shared Voting Power

 

-0-

   7   

Sole Dispositive Power

 

-0-

   8   

Shared Dispositive Power

 

631,481 (1)(2)

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

631,481 (1)(2)

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ¨

 

11  

Percent of Class Represented by Amount in Row (9)

 

0.7% (3)

12  

Type of Reporting Person

 

OO

 

(1) James E. Douglas III also holds a warrant to purchase 231,481 shares of common stock at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(2) Kevin Douglas has dispositive power with respect to the securities held by James E. Douglas III.
(3) Based on 88,245,725 shares of common stock outstanding, calculated as follows (a) 71,645,725 shares of the Issuer’s common stock outstanding as of November 7, 2012 as reported on its Form 10-Q for the quarter ended September 30, 2012 filed with the SEC on November 8, 2012, and (b) an additional 16,600,000 shares issued in a private placement, as disclosed by the Issuer in a current report on Form 8-K/A filed with the SEC on January 31, 2013.

 

Page 4 of 10


SCHEDULE 13G

 

CUSIP No. 89365K206      

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

K&M Douglas Trust (1)

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

California

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

Sole Voting Power

 

3,185,925 (2)

   6   

Shared Voting Power

 

-0-

   7   

Sole Dispositive Power

 

3,185,925 (2)

   8   

Shared Dispositive Power

 

-0-

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,185,925 (2)

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ¨

 

11  

Percent of Class Represented by Amount in Row (9)

 

3.6% (3)

12  

Type of Reporting Person

 

OO

 

(1) Kevin Douglas and Michelle Douglas, husband and wife, are beneficiaries and co-trustees.
(2) The K&M Douglas Trust also holds a warrant to purchase 925,925 shares of common stock at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(3) Based on 88,245,725 shares of common stock outstanding, calculated as follows (a) 71,645,725 shares of the Issuer’s common stock outstanding as of November 7, 2012 as reported on its Form 10-Q for the quarter ended September 30, 2012 filed with the SEC on November 8, 2012, and (b) an additional 16,600,000 shares issued in a private placement, as disclosed by the Issuer in a current report on Form 8-K/A filed with the SEC on January 31, 2013.

 

Page 5 of 10


SCHEDULE 13G

 

CUSIP No. 89365K206      

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

Douglas Family Trust (1)

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

California

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

Sole Voting Power

 

1,513,518 (2)

   6   

Shared Voting Power

 

-0-

   7   

Sole Dispositive Power

 

-0-

   8   

Shared Dispositive Power

 

1,513,518 (2)(3)

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,513,518 (2)

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ¨

 

11  

Percent of Class Represented by Amount in Row (9)

 

1.7% (4)

12  

Type of Reporting Person

 

OO

 

(1) James E. Douglas, Jr. and Jean A. Douglas, husband and wife, are co-trustees.
(2) The Douglas Family Trust also holds a warrant to purchase 393,518 shares of common stock at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(3) Kevin Douglas has dispositive power with respect to the securities held by the Douglas Family Trust.
(4) Based on 88,245,725 shares of common stock outstanding, calculated as follows (a) 71,645,725 shares of the Issuer’s common stock outstanding as of November 7, 2012 as reported on its Form 10-Q for the quarter ended September 30, 2012 filed with the SEC on November 8, 2012, and (b) an additional 16,600,000 shares issued in a private placement, as disclosed by the Issuer in a current report on Form 8-K/A filed with the SEC on January 31, 2013.

 

Page 6 of 10


SCHEDULE 13G

 

CUSIP No. 89365K206      

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

James Douglas and Jean Douglas Irrevocable Descendants’ Trust (1)

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

California

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

     

Sole Voting Power

 

3,183,888 (2)

   6   

Shared Voting Power

 

-0-

   7   

Sole Dispositive Power

 

3,183,888 (2)

   8   

Shared Dispositive Power

 

-0-

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,183,888 (2)

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ¨

 

11  

Percent of Class Represented by Amount in Row (9)

 

3.6% (3)

12  

Type of Reporting Person

 

OO

 

(1) Kevin Douglas and Michelle Douglas, husband and wife, are co-trustees.
(2) The James Douglas and Jean Douglas Irrevocable Descendants’ Trust also holds a warrant to purchase 763,888 shares of common stock at a price of $1.08 per share; however, this warrant is exercisable only to the extent that such exercise would not cause the beneficial ownership of this affiliated group to exceed 9.99% of the outstanding shares.
(3) Based on 71,379,822 shares of common stock outstanding, calculated as follows (a) 49,379,822 Based on 88,245,725 shares of common stock outstanding, calculated as follows (a) 71,645,725 shares of the Issuer’s common stock outstanding as of November 7, 2012 as reported on its Form 10-Q for the quarter ended September 30, 2012 filed with the SEC on November 8, 2012, and (b) an additional 16,600,000 shares issued in a private placement, as disclosed by the Issuer in a current report on Form 8-K/A filed with the SEC on January 31, 2013.

 

Page 7 of 10


SCHEDULE 13G
Item 1.   
        (a)    Name of Issuer:
   Transgenomic, Inc.
        (b)    Address of Issuer’s Principal Executive Offices:
   12325 Emmet Street
   Omaha, NE 68146
Item 2.   
        (1)(a)    NAME OF PERSONS FILING:
   Kevin Douglas
   Michelle Douglas
   James E. Douglas III
        (b)    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
   125 E. Sir Francis Drake Blvd., Ste 400
   Larkspur, CA 94939
        (c)    CITIZENSHIP:
   United States
        (d)    TITLE OF CLASS OF SECURITIES:
   Common Stock
        (e)    CUSIP NUMBER:
   8936K206
        (2)(a)    NAME OF PERSONS FILING:
   K&M Douglas Trust
   Douglas Family Trust
   James Douglas and Jean Douglas Irrevocable Descendants’ Trust
        (b)    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
   125 E. Sir Francis Drake Blvd., Ste 400
   Larkspur, CA 94939
        (c)    CITIZENSHIP:
   California
        (d)    TITLE OF CLASS OF SECURITIES:
   Common Stock

 

Page 8 of 10


(e)    CUSIP NUMBER:
   8936K206
Item 3.    If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
        (a)    ¨     Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
        (b)    ¨     Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
        (c)    ¨     Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
        (d)    ¨     Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
        (e)    ¨     An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
        (f)    ¨     An employee benefit plan or endowment fund in accordance with §240.13d- 1(b)(1)(ii)(F);
        (g)    ¨     A parent holding company or control person in accordance with §240.13d- 1(b)(1)(ii)(G);
        (h)    ¨     A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
        (i)    ¨     A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
        (j)    ¨     Group, in accordance with §240.13d-1(b)(1)(ii)(J)
Not Applicable.

 

Page 9 of 10


Item 4. Ownership

Reference is made as to each of the Reporting Persons hereunder to Rows 5-9 and 11 of each of the cover pages of this Schedule 13G and associated footnotes, which are incorporated by reference herein.

Each of the Reporting Persons hereunder may be deemed a member of a “group” within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934 (the “Exchange Act”), or Rule 13d-5 promulgated under the Exchange Act with one or more of the other Reporting Persons hereunder. Although the Reporting Persons are reporting such securities as if they were members of a “group,” the filing of this Schedule 13G shall not be construed as an admission by any Reporting Person that such Reporting Person is a beneficial owner of any securities other than those directly held by such Reporting Person.

 

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:    ¨

 

Item 6. Ownership of More Than Five Percent on Behalf of Another Person

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

See Item 4 of this Schedule 13G/A and the Joint Filing Agreement attached hereto as Exhibit A.

 

Item 9. Notice of Dissolution of Group

Not applicable.

 

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 10 of 10


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 14, 2013  

* Kevin Douglas

  KEVIN DOUGLAS
Date: February 14, 2013  

* Michelle Douglas

  MICHELLE DOUGLAS
Date: February 14, 2013  

* James E. Douglas III

  JAMES E. DOUGLAS III
  K&M DOUGLAS TRUST
Date: February 14, 2013  

* Kevin Douglas

  By:    Kevin Douglas
  Title: Trustee
Date: February 14, 2013  

* Michelle Douglas

  By:    Michelle Douglas
  Title: Trustee
  DOUGLAS FAMILY TRUST
Date: February 14, 2013  

* James E. Douglas, Jr.

  By:    James E. Douglas, Jr.
  Title: Trustee
Date: February 14, 2013  

* Jean A. Douglas

  By:    Jean A. Douglas
  Title: Trustee
  JAMES DOUGLAS AND JEAN DOUGLAS
  IRREVOCABLE DESCENDANTS’ TRUST
Date: February 14, 2013  

* Kevin Douglas

  By:    Kevin Douglas
  Title: Trustee
Date: February 14, 2013  

* Michelle Douglas

  By: Michelle Douglas
  Title: Trustee

 

*By:  

/s/ Eileen Wheatman

  Eileen Wheatman
  Attorney-in-fact


EXHIBIT A

JOINT FILING AGREEMENT

This Joint Filing Agreement (this “Agreement”) hereby confirms the agreement by and among all of the undersigned that the Schedule 13G/A to which this Agreement is attached as Exhibit A with respect to the beneficial ownership of the undersigned of shares Common Stock of Transgenomic, Inc. is being filed on behalf of each of the undersigned. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

Date: February 14, 2013  

* Kevin Douglas

  KEVIN DOUGLAS
Date: February 14, 2013  

* Michelle Douglas

  MICHELLE DOUGLAS
Date: February 14, 2013  

* James E. Douglas III

  JAMES E. DOUGLAS III
  K&M DOUGLAS TRUST
Date: February 14, 2013  

* Kevin Douglas

  By:    Kevin Douglas
  Title: Trustee
Date: February 14, 2013  

* Michelle Douglas

  By:    Michelle Douglas
  Title: Trustee
  DOUGLAS FAMILY TRUST
Date: February 14, 2013  

* James E. Douglas, Jr.

  By:    James E. Douglas, Jr.
  Title: Trustee
Date: February 14, 2013  

* Jean A. Douglas

  By:    Jean A. Douglas
  Title: Trustee
  JAMES DOUGLAS AND JEAN DOUGLAS
  IRREVOCABLE DESCENDANTS’ TRUST
Date: February 14, 2013  

* Kevin Douglas

  By:    Kevin Douglas
  Title: Trustee
Date: February 14, 2013  

* Michelle Douglas

  By: Michelle Douglas
  Title: Trustee

 

*By:  

/s/ Eileen Wheatman

  Eileen Wheatman
  Attorney-in-fact